Vasopharm Sees Path Forward For Traumatic Brain Injury Drug

Ronopterin Misses Primary Endpoint In NOSTRA III Trial

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.